Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin versus noradrenaline for vasoplegic syndrome in renal-risk cardiac surgery patients
2022-500419-38-00Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Dec 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vasoplegia comparing Vasopressin arm with Noradrenaline arm (2 arms). Primary endpoint: Renal complication or death by day 7. Started Dec 2022; status: completed.
02
Drugs
vasopressinnorepinephrine
03
Conditions
Vasoplegia
Beyond the preview
Go deeper on 2022-500419-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500419-38-00.